SBS decreases the tumor weight and increases serum interleukin 2 (IL-2), interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α) in mice with xenografted hepatocellular cancers [6]. The gene discussed is IL2; the disease is neoplasm.